Tonix Pharmaceuticals Holding Corp.

Ownership Transactions Reported by 14 Insiders

Symbol
TNXP on Nasdaq
Location
26 Main Street, Suite 101, Chatham, NJ

Insiders trading volume in the past year

Tonix Pharmaceuticals Holding Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Seth Lederman Chief Executive Officer, Director $86.3K +$86.2K +80561% May 15, 2025
Carolyn E. Taylor Director $15.1K +$15.1K Aug 21, 2025
James Treco Director $9K +$9K Aug 20, 2025
Daniel Wintner Goodman Director $8.55K May 25, 2021
Siobhan Fogarty Chief Technology Officer $0 Feb 25, 2025
Richard H. Bagger Director $0 May 13, 2025
Adeoye Y. Olukotun Director $0 May 13, 2025
Margaret Smith Bell Director $0 May 13, 2025
Gregory M. Sullivan Chief Medical Officer $0 Feb 5, 2025
Bradley Saenger Chief Financial Officer $0 Feb 5, 2025
Jessica Morris Chief Operating Officer Feb 5, 2025
James Randolph Hunter Jr Director Jun 12, 2025
Richard Newcomb Stillwell Director May 13, 2025
David L. Grange Director May 13, 2025

Recent Insider Transactions by Companies or Individuals for Tonix Pharmaceuticals Holding Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.